Total Payments
$11,488
2024 Payments
$2,641
Companies
39
Transactions
765
Medicare Patients
2,522
Medicare Billing
$158,869
Payment Breakdown by Category
Food & Beverage$11,488 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,488 | 765 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,577 | 126 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,384 | 76 | $0 (2024) |
| Lilly USA, LLC | $1,185 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $987.48 | 76 | $0 (2024) |
| ABBVIE INC. | $709.81 | 62 | $0 (2024) |
| PFIZER INC. | $605.84 | 43 | $0 (2024) |
| Abbott Laboratories | $602.04 | 31 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $530.63 | 33 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $355.68 | 25 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $324.60 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,641 | 157 | AstraZeneca Pharmaceuticals LP ($475.97) |
| 2023 | $2,376 | 161 | Lilly USA, LLC ($365.33) |
| 2022 | $3,077 | 211 | Novo Nordisk Inc ($452.43) |
| 2021 | $3,394 | 236 | Novo Nordisk Inc ($538.31) |
All Payment Transactions
765 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardio-renal | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.63 | General |
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: Biological | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Oncology | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Biological | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.88 | General |
| 10/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Oncology | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: Obesity | ||||||
| 10/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.67 | General |
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 513 | 647 | $111,500 | $25,882 |
| 2022 | 10 | 622 | 791 | $137,925 | $31,005 |
| 2021 | 10 | 648 | 746 | $131,333 | $50,053 |
| 2020 | 11 | 739 | 824 | $145,028 | $51,929 |
Total Patients
2,522
Total Services
3,008
Medicare Billing
$158,869
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 284 | $40,328 | $10,741 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 140 | $29,260 | $5,371 | 18.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $7,935 | $4,229 | 53.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 23 | 23 | $1,886 | $1,744 | 92.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 107 | 107 | $24,075 | $1,708 | 7.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 16 | $5,520 | $692.05 | 12.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $984.00 | $688.32 | 70.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $615.00 | $430.20 | 70.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 23 | 23 | $897.00 | $279.65 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 197 | 312 | $44,304 | $11,914 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 153 | $31,977 | $5,645 | 17.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 177 | 177 | $39,825 | $3,693 | 9.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $6,348 | $3,339 | 52.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 30 | $2,390 | $2,053 | 85.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 23 | 26 | $8,970 | $1,354 | 15.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $1,265 | $1,251 | 98.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 32 | 32 | $1,312 | $869.03 | 66.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 26 | 26 | $1,066 | $711.11 | 66.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 12 | 12 | $468.00 | $174.57 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 216 | 216 | $48,600 | $23,007 | 47.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 170 | 238 | $33,796 | $7,917 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 131 | $27,379 | $6,164 | 22.5% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 16 | 16 | $3,712 | $3,705 | 99.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 20 | 20 | $2,300 | $2,300 | 100.0% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 16 | 17 | $5,865 | $2,132 | 36.3% |
About Ganna Starkey, APRN
Ganna Starkey, APRN is a Acute Care healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1962848846.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ganna Starkey, APRN has received a total of $11,488 in payments from pharmaceutical and medical device companies, with $2,641 received in 2024. These payments were reported across 765 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($11,488).
As a Medicare-enrolled provider, Starkey has provided services to 2,522 Medicare beneficiaries, totaling 3,008 services with total Medicare billing of $158,869. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Tulsa, OK
- Active Since 05/17/2013
- Last Updated 10/13/2023
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1962848846
Products in Payments
- FARXIGA (Drug) $940.94
- TRELEGY ELLIPTA (Drug) $729.64
- Kerendia (Drug) $530.63
- JARDIANCE (Drug) $491.99
- MOUNJARO (Drug) $461.62
- NURTEC ODT (Drug) $437.61
- AIRSUPRA (Drug) $331.41
- EMGALITY (Drug) $330.92
- TRINTELLIX (Drug) $312.41
- Rybelsus (Drug) $297.94
- XARELTO (Drug) $292.08
- FREESTYLE LIBRE 3 (Device) $277.58
- Wegovy (Drug) $252.71
- UBRELVY (Drug) $243.22
- NEXLETOL (Drug) $240.11
- VRAYLAR (Drug) $237.64
- XIFAXAN (Drug) $236.52
- Saxenda (Drug) $234.64
- Livalo (Drug) $233.24
- Cologuard Collection Kit (Device) $225.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Tulsa
Pavel Buzadzhi
Acute Care — Payments: $16,980
Acute Care $16,980
Christopher Gordon, Crnp, CRNP
Acute Care — Payments: $11,428
Acute Care $11,428
Jerrie Morales, Aprn, APRN
Acute Care — Payments: $10,500
Acute Care $10,500
Georgianne Tokarchik
Acute Care — Payments: $8,071
Acute Care $8,071
Kelli Leek
Acute Care — Payments: $8,033
Acute Care $8,033
Brian Hutchinson, Aprn, APRN
Acute Care — Payments: $6,844
Acute Care $6,844